# Ameliorating Contrast Induced Nephropathy After Coronary Angiography

> **NCT06139952** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 120 (actual)

## Conditions studied

- Coronary Artery Disease
- Nephropathy; Toxic, Drugs

## Interventions

- **DRUG:** Atorvastatin 80mg
- **DRUG:** N-acetyl cysteine
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT06139952
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06139952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06139952, "Ameliorating Contrast Induced Nephropathy After Coronary Angiography". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06139952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*